Abstract
The COVID-19 pandemic has had a dramatic impact on the provision of acute inpatient care with specialists from all disciplines having to manage patients outside of their usual speciality areas. In many UK hospitals diabetes consultants and diabetes inpatient specialist nurses have been redeployed to the wards to care for COVID-19 positive or suspected cases. Consequently, clinicians relatively unfamiliar with managing hyperglycaemia have been required to do so as the usual input from diabetes specialist teams has not been possible in many areas.
| Original language | English |
|---|---|
| Pages (from-to) | 1210-1213 |
| Number of pages | 4 |
| Journal | Diabetic Medicine |
| Volume | 37 |
| Issue number | 7 |
| Early online date | 17 May 2020 |
| DOIs | |
| Publication status | Published - 18 Jun 2020 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
ASJC Scopus subject areas
- Internal Medicine
- Endocrinology, Diabetes and Metabolism
- Endocrinology
Fingerprint
Dive into the research topics of 'New Guidance on Managing Inpatient Hyperglycaemia during the COVID-19 Pandemic'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver